Milestone Pharmaceuticals Stock Short Ratio
| MIST Stock | USD 1.94 0.05 2.51% |
Milestone Pharmaceuticals fundamentals help investors to digest information that contributes to Milestone Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Milestone Stock. The fundamental analysis module provides a way to measure Milestone Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Milestone Pharmaceuticals stock.
Milestone |
Milestone Pharmaceuticals Company Short Ratio Analysis
Milestone Pharmaceuticals' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Milestone Pharmaceuticals Short Ratio | 0.71 X |
Most of Milestone Pharmaceuticals' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Milestone Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Milestone Pharmaceuticals has a Short Ratio of 0.71 times. This is 81.79% lower than that of the Pharmaceuticals sector and 90.42% lower than that of the Health Care industry. The short ratio for all United States stocks is 82.25% higher than that of the company.
Milestone Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Milestone Pharmaceuticals' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Milestone Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Milestone Pharmaceuticals by comparing valuation metrics of similar companies.Milestone Pharmaceuticals is currently under evaluation in short ratio category among its peers.
Milestone Fundamentals
| Return On Equity | -2.78 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 113.62 M | ||||
| Shares Outstanding | 53.35 M | ||||
| Shares Owned By Insiders | 0.65 % | ||||
| Shares Owned By Institutions | 46.26 % | ||||
| Number Of Shares Shorted | 398.73 K | ||||
| Price To Earning | (4.44) X | ||||
| Price To Book | 9.78 X | ||||
| Price To Sales | 77.32 X | ||||
| EBITDA | (42.1 M) | ||||
| Net Income | (41.52 M) | ||||
| Cash And Equivalents | 86.24 M | ||||
| Cash Per Share | 2.87 X | ||||
| Total Debt | 54.8 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 21.26 X | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (28.85 M) | ||||
| Short Ratio | 0.71 X | ||||
| Earnings Per Share | (0.67) X | ||||
| Target Price | 10.25 | ||||
| Number Of Employees | 33 | ||||
| Beta | 1.84 | ||||
| Market Capitalization | 126.98 M | ||||
| Total Asset | 75.5 M | ||||
| Retained Earnings | (367.55 M) | ||||
| Working Capital | 65.8 M | ||||
| Current Asset | 110.42 M | ||||
| Current Liabilities | 7.17 M | ||||
| Net Asset | 75.5 M |
About Milestone Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Milestone Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Milestone Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Milestone Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.